Generic Medicine Pharma
Darbagen 0.75 mcg/kg
Darbagen 0.75 mcg/kg
Darbagen 0.75mcg/kg is an injectable erythropoiesis-stimulating agent used to treat anemia caused by chronic kidney disease, chemotherapy, or other conditions. It contains Darbepoetin alfa, which stimulates red blood cell production and reduces the need for blood transfusions.
| Field | Details |
|---|---|
| Original Brand | Aranesp |
| Generic Brand | Darbagen 0.75 |
| Generic Name | Darbepoetin alfa 0.75mcg/kg |
| Pack Size | Single-use vial / prefilled syringe |
| Use / Indications | Anemia, CKD-related anemia, Chemotherapy-induced anemia |
| Manufacturer | Everest Pharmaceuticals Ltd. (Produced in Bangladesh) |
| Status | Prescription Only Medicine |
ntroduction to Aranesp (Darbepoetin alfa) 0.75mcg/kg
Aranesp (Darbepoetin alfa) 0.75mcg/kg is a prescription medicine used to treat anemia associated with chronic kidney disease, chemotherapy, or other medical conditions. Darbagen 0.75mcg/kg, a generic version, contains the same active ingredient, providing similar therapeutic effects under medical supervision.
Aranesp (Darbepoetin alfa) 0.75mcg/kg is classified under Prescription Medicines, Hematology Medicines, Erythropoiesis-Stimulating Agents, and Anemia Therapies. It works by stimulating the bone marrow to produce red blood cells, helping improve hemoglobin levels.
What Is Aranesp (Darbepoetin alfa)?
Aranesp is the brand name for Darbepoetin alfa, an injectable medicine used to manage anemia.
Darbepoetin alfa belongs to erythropoiesis-stimulating agents (ESAs), which help increase red blood cell production and improve oxygen transport in the body.
Generic versions such as Darbagen 0.75mcg/kg may be used depending on physician recommendation and availability.
Drug Class and Mechanism of Action
Darbepoetin alfa is classified as an erythropoiesis-stimulating agent with potent red blood cell production properties.
How Darbepoetin alfa Works
- Stimulates bone marrow to produce red blood cells
- Increases hemoglobin levels
- Reduces the need for blood transfusions
- Helps improve oxygen delivery to tissues
How Aranesp Works in the Body
After subcutaneous or intravenous administration, Darbepoetin alfa binds to erythropoietin receptors in the bone marrow, stimulating red blood cell production.
Key Actions of Darbepoetin alfa
- Increases hemoglobin and hematocrit
- Reduces anemia-related fatigue
- Decreases dependence on blood transfusions
- Supports overall quality of life in anemic patients
Darbagen 0.75mcg/kg provides similar benefits as Aranesp when used as prescribed.
Medical Uses of Aranesp (Darbepoetin alfa) 0.75mcg/kg
Aranesp for Anemia
Aranesp 0.75mcg/kg is prescribed for:
Potential Benefits
- Treats anemia associated with chronic kidney disease
- Reduces fatigue and weakness
- Minimizes need for frequent blood transfusions
Generic alternatives like Darbagen 0.75mcg/kg may also be used under supervision.
Other Uses
- Anemia caused by chemotherapy
- Preoperative anemia management
- Supporting red blood cell levels in chronic diseases
Who Can Take Darbagen 0.75mcg/kg?
This medicine should be taken under medical guidance.
Eligibility Criteria
Patients may be prescribed Aranesp or Darbagen if they:
- Have clinically significant anemia
- Are undergoing chemotherapy or dialysis
- Have been evaluated for cardiovascular risks
Who Should Avoid Aranesp (Darbepoetin alfa) 0.75mcg/kg
Aranesp should NOT be used by:
- Patients with uncontrolled hypertension
- Individuals with hypersensitivity to Darbepoetin alfa
- Patients with normal hemoglobin levels (unless medically indicated)
Aranesp (Darbepoetin alfa) 0.75mcg/kg Dosage and Administration
Standard Dosage Guidelines
- Typical dose: 0.75mcg/kg once weekly, subcutaneously or intravenously
- Administer exactly as prescribed by a healthcare professional
- Monitor hemoglobin levels regularly
Dosage Adjustments
Doctors may adjust the dose depending on:
- Hemoglobin response
- Kidney function or chemotherapy schedule
- Individual tolerance and side effects
Side Effects of Aranesp (Darbepoetin alfa) 0.75mcg/kg
Common Side Effects
- Mild injection site reactions
- Headache
- Fatigue
- Nausea
Serious Side Effects
- High blood pressure
- Blood clots (thrombosis)
- Stroke or heart attack risk in some patients
- Severe allergic reactions
Patients should report any unusual symptoms to their doctor immediately.
Storage:
Store in a refrigerator at 2–8°C. Do not freeze. Protect from light and keep out of reach of children.
Frequently Asked Questions (FAQs)
1. How soon does Aranesp (Darbepoetin alfa) 0.75mcg/kg work?
Red blood cell levels usually start rising within 2–4 weeks.
2. Can it be used during chemotherapy?
Yes, it is often prescribed to reduce chemotherapy-induced anemia.
3. Can I self-inject Darbagen at home?
Self-administration is possible if trained by a healthcare provider.
4. Is Darbagen 0.75mcg/kg the same as Aranesp?
Yes. It contains Darbepoetin alfa, the same active ingredient as Aranesp.
5. Do I need a prescription to buy Aranesp (Darbepoetin alfa) 0.75mcg/kg ?
Yes. It is a prescription-only medicine and must be used under medical supervision.
Medical Disclaimer
The information provided is for educational purposes only and should not be considered medical advice. Aranesp (Darbepoetin alfa) is a prescription-only medicine and must be used under qualified healthcare supervision. Always consult your physician before starting, stopping, or changing any medication.





